Britannia Life Sciences Inc.
BLAB
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.59M | 618.60K | 4.50M | 5.46M | 688.30K |
| Total Receivables | 404.10K | 214.40K | 147.80K | 158.70K | 792.10K |
| Inventory | -- | -- | -- | -- | 135.00K |
| Prepaid Expenses | 49.30K | 9.20K | 9.40K | 17.00K | 13.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 334.90K | 1.33M | 1.32M | 1.27M | -- |
| Total Current Assets | 12.37M | 2.18M | 5.98M | 6.91M | 1.63M |
|
|
|||||
| Total Current Assets | 12.37M | 2.18M | 5.98M | 6.91M | 1.63M |
| Net Property, Plant & Equipment | 69.30K | 80.60K | 93.90K | 99.50K | 427.40K |
| Long-term Investments | -- | -- | -- | -- | 13.02M |
| Goodwill | -- | -- | -- | -- | 13.02M |
| Total Other Intangibles | -- | -- | -- | -- | 330.90K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00 | -- | -- | -- | -- |
| Total Assets | 16.09M | 7.41M | 7.19M | 8.08M | 15.41M |
|
|
|||||
| Total Accounts Payable | 2.44M | 982.70K | 1.04M | 1.54M | 1.51M |
| Total Accrued Expenses | 899.20K | 1.04M | 751.30K | 863.00K | 1.02M |
| Short-term Debt | 21.20K | 21.20K | 21.70K | 20.40K | 19.80K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 123.60K | 121.10K | 125.20K | 119.60K | 1.69M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 3.86M |
| Total Other Current Liabilities | -- | -- | -- | -- | 3.86M |
| Total Current Liabilities | 3.49M | 2.17M | 1.94M | 2.54M | 8.10M |
|
|
|||||
| Total Current Liabilities | 3.49M | 2.17M | 1.94M | 2.54M | 8.10M |
| Long-Term Debt | -- | 1.56M | 1.12M | 1.07M | 3.07M |
| Short-term Debt | 21.20K | 21.20K | 21.70K | 20.40K | 19.80K |
| Capital Leases | 36.40K | 52.60K | 69.50K | 79.60K | 164.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 21.50K |
| Total Liabilities | 3.52M | 3.78M | 3.13M | 3.69M | 11.35M |
|
|
|||||
| Common Stock & APIC | 14.96M | 14.73M | 15.04M | 14.27M | 14.26M |
| Retained Earnings | -1.65M | -10.33M | -10.25M | -9.25M | -13.51M |
| Treasury Stock & Other | -746.00K | -771.10K | -725.90K | -644.80K | 68.50K |
| Total Common Equity | 12.57M | 3.63M | 4.07M | 4.38M | 821.40K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.57M | 3.63M | 4.07M | 4.38M | 821.40K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | 3.23M |
| Total Equity | 12.57M | 3.63M | 4.07M | 4.38M | 4.06M |
|
|
|||||